Qiagen NV | QIA - EPS Earnings Per Share

Stock Price
28.47
Daily Change
-0.13 -0.44%
Monthly
-18.67%
Yearly
-25.21%
Q2 Forecast
27.51

Qiagen NV reported $0.46 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.46 0.46 0.49 Apr/27
FY2025Q4 Dec/2025 0.50 0.52 0.59 Feb/04
FY2025Q3 Sep/2025 0.53 0.5 0.54 Nov/04
FY2025Q2 Jun/2025 0.60 0.53 0.51 Aug/05
FY2025Q1 Mar/2025 0.49 0.47 0.43 May/07




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
argenx SE USD 4.7 2.1 Mar/2026
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Qiagen NV USD 0.46 0.06 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026